Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

How I manage sickle cell patients with high transcranial doppler results.

Brewin J, Kaya B, Chakravorty S.

Br J Haematol. 2017 Nov;179(3):377-388. doi: 10.1111/bjh.14850. Epub 2017 Aug 2. Review.

PMID:
28771666
2.

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone C, Lee MT, Kwiatkowski JL, Jackson S, Miller ST, Roberts C, Heeney MM, Kalfa TA, Nelson S, Imran H, Nottage K, Alvarez O, Rhodes M, Thompson AA, Rothman JA, Helton KJ, Roberts D, Coleman J, Bonner MJ, Kutlar A, Patel N, Wood J, Piller L, Wei P, Luden J, Mortier NA, Stuber SE, Luban NL, Cohen AR, Pressel S, Adams RJ.

Lancet. 2016 Feb 13;387(10019):661-70. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6.

3.

Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.

Sheehan VA, Hansbury EN, Smeltzer MP, Fortner G, McCarville MB, Aygun B.

Pediatr Blood Cancer. 2013 Sep;60(9):1499-502. doi: 10.1002/pbc.24569. Epub 2013 Apr 26.

PMID:
23625812
4.

The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.

Cherry MG, Greenhalgh J, Osipenko L, Venkatachalam M, Boland A, Dundar Y, Marsh K, Dickson R, Rees DC.

Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430. Review.

5.

Implementation of transcranial Doppler ultrasonography screening and primary stroke prevention in urban and rural sickle cell disease populations.

Hussain S, Nichols F, Bowman L, Xu H, Neunert C.

Pediatr Blood Cancer. 2015 Feb;62(2):219-223. doi: 10.1002/pbc.25306. Epub 2014 Nov 8.

PMID:
25381872
6.

Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease.

Kwiatkowski JL, Yim E, Miller S, Adams RJ; STOP 2 Study Investigators.

Pediatr Blood Cancer. 2011 May;56(5):777-82. doi: 10.1002/pbc.22951. Epub 2010 Dec 23.

7.

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.

Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE.

Blood. 2007 Aug 1;110(3):1043-7. Epub 2007 Apr 11.

8.

Screening children for sickle cell vasculopathy: guidelines for transcranial Doppler evaluation.

Bulas D.

Pediatr Radiol. 2005 Mar;35(3):235-41. Epub 2005 Feb 10. Review.

PMID:
15703903
9.

Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.

Lagunju I, Brown BJ, Sodeinde O.

Pediatr Blood Cancer. 2015 Sep;62(9):1587-91. doi: 10.1002/pbc.25529. Epub 2015 Apr 1.

PMID:
25847050
10.

Transcranial Doppler changes in children with sickle cell disease on transfusion therapy.

Minniti CP, Gidvani VK, Bulas D, Brown WA, Vezina G, Driscoll MC.

J Pediatr Hematol Oncol. 2004 Oct;26(10):626-30.

PMID:
15454832
11.

Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing.

Nichols FT, Jones AM, Adams RJ.

J Neuroimaging. 2001 Oct;11(4):354-62.

PMID:
11677874
12.

The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.

Buchanan ID, James-Herry A, Osunkwo I.

J Pediatr Hematol Oncol. 2013 Oct;35(7):543-6. doi: 10.1097/MPH.0b013e318279caae.

PMID:
23211694
13.

Normalized transcranial Doppler velocities, stroke prevention and improved pulmonary function after stem cell transplantation in children with sickle cell anemia.

Mynarek M, Bettoni da Cunha Riehm C, Brinkmann F, Weißenborn K, Tell-Lüersen M, Heuft HG, Maecker-Kolhoff B, Sykora KW.

Klin Padiatr. 2013 May;225(3):127-32. doi: 10.1055/s-0033-1333754. Epub 2013 Apr 26.

PMID:
23625683
14.

Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Wang WC, Dwan K.

Cochrane Database Syst Rev. 2013 Nov 14;(11):CD003146. doi: 10.1002/14651858.CD003146.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Jan 17;1:CD003146.

15.

TCD in sickle cell disease: an important and useful test.

Adams RJ.

Pediatr Radiol. 2005 Mar;35(3):229-34. Epub 2005 Feb 10. Review.

PMID:
15703904
16.

Big strokes in small persons.

Adams RJ.

Arch Neurol. 2007 Nov;64(11):1567-74. Review.

PMID:
17998439
17.

Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation.

Bulas DI, Jones A, Seibert JJ, Driscoll C, O'Donnell R, Adams RJ.

Pediatr Radiol. 2000 Nov;30(11):733-8.

PMID:
11100487
18.

Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Doree C, Abboud MR.

Cochrane Database Syst Rev. 2017 May 13;5:CD012389. doi: 10.1002/14651858.CD012389.pub2. Review.

19.

Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.

Bishop S, Matheus MG, Abboud MR, Cane ID, Adams RJ, Jackson SM, Kalpatthi R.

Blood Cells Mol Dis. 2011 Aug 15;47(2):125-8. doi: 10.1016/j.bcmd.2011.06.002. Epub 2011 Jul 2.

PMID:
21724428
20.

Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia.

Jones AM, Seibert JJ, Nichols FT, Kinder DL, Cox K, Luden J, Carl EM, Brambilla D, Saccente S, Adams RJ.

Pediatr Radiol. 2001 Jul;31(7):461-9.

PMID:
11486797

Supplemental Content

Support Center